|
【结 构 式】
|
【药物名称】Rizatriptan benzoate, MK-462, MK-0462, Maxalt-MLT, Maxalt 【化学名称】3-[2-(Dimethylamino)ethyl]-5-(1,2,4-triazol-1-ylmethyl)indole benzoate 【CA登记号】145202-66-0, 144034-80-0 (free base), 159776-67-7 (sulfate salt (2:1), monohydrate), 153764-00-2 (sulfate salt(10:5), heptahydra 【 分 子 式 】C22H25N5O2 【 分 子 量 】391.47685 |
【开发单位】Kyorin (Supplier), Merck & Co. (Originator), Merck Frosst (Originator), Eisai (Marketer) 【药理作用】Acute Attacks of Migraine, Treatment of, ANALGESIC AND ANESTHETIC DRUGS, Antimigraine Drugs, 5-HT1B Agonists, 5-HT1D Agonists |
合成路线1
1) The iodination of 4-(1,2,4-triazol-1-ylmethyl)aniline (I) with ICl and CaCO3 in methanol/water gives the 2-iodoaniline (II), which is cyclized with 1-(triethylsilyl)-4-(triethylsilyloxy)-1-butyne (III) by means of paladium acetate and Na2CO3 in hot DMF yielding 5-(1,2,4-triazol-1-ylmethyl)-3-[2-(triethylsilyloxy)ethyl]-1H-indole (IV). The desilylation of (IV) with HCl in methanol affords the corresponding alcohol (V), which is condensed with dimethylamine by means of methanesulfonyl chloride and triethylamine to give MK-0462 free base (VI). Finally, this compound is treated with benzoic acid in isopropyl alcohol/isopropyl acetate solution.

| 【1】 Castañer, J.; Mealy, N.; Rabassseda, X.; MK-0462. Drugs Fut 1995, 20, 7, 676. |
| 【2】 Lieberman, D.R.; Reamer, R.A.; Reider, P.J.; Cottrell, I.F.; Chen, C.-Y.; Verhoeven, T.R.; Larsen, R.D.; Houghton, P.G.; Synthesis of the 5-HT1D receptor agonist MK-0462 via a Pd-catalyzed coupling reaction. Tetrahedron Lett 1994, 35, 38, 6981-4. |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| 10202 | Benzoic acid | 65-85-0 | C7H6O2 | 详情 | 详情 | |
| (I) | 16860 | 4-(1H-1,2,4-triazol-1-ylmethyl)aniline; 4-(1H-1,2,4-triazol-1-ylmethyl)phenylamine | C9H10N4 | 详情 | 详情 | |
| (II) | 16861 | 2-iodo-4-(1H-1,2,4-triazol-1-ylmethyl)phenylamine; 2-iodo-4-(1H-1,2,4-triazol-1-ylmethyl)aniline | C9H9IN4 | 详情 | 详情 | |
| (III) | 16862 | triethylsilyl 4-(triethylsilyl)-3-butynyl ether; triethyl[[4-(triethylsilyl)-3-butynyl]oxy]silane | 160194-28-5 | C16H34OSi2 | 详情 | 详情 |
| (IV) | 16863 | 2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethyl triethylsilyl ether; 5-(1H-1,2,4-triazol-1-ylmethyl)-3-[2-[(triethylsilyl)oxy]ethyl]-1H-indole | C19H28N4OSi | 详情 | 详情 | |
| (V) | 16864 | 2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-1-ethanol | C13H14N4O | 详情 | 详情 | |
| (VI) | 16865 | N,N-dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-1-ethanamine; N,N-dimethyl-N-[2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethyl]amine | C15H19N5 | 详情 | 详情 |
合成路线2
2) The condensation of 4-nitrobenzyl bromide (VI) with 1,2,4-triazole sodium salt (VII) in DMF gives 1-(4-nitrobenzyl)-1,2,4-triazole (VIII), which is reduced with H2 over Pd/C in ethanol/ethyl acetate yielding the aniline (I). The diazotization of (I) with NaNO2/HCl followed by reduction with SnCl2 affords the corresponding hydrazine (IX), which is cyclized with 4-chlorobutanal dimethylacetal (X) by means of HCl in refluxing ethanol/water to afford 2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl] ethylamine (XI). Finally, this amine is methylated with formaldehyde, sodium cyanoborohydride and acetic acid in methanol.

| 【1】 Castañer, J.; Mealy, N.; Rabassseda, X.; MK-0462. Drugs Fut 1995, 20, 7, 676. |
| 【2】 Baker, R.; Matassa, V.G.; Street, L.J. (Merck Sharp & Dohme Ltd.); Imidazole, triazole and tetrazole derivs. EP 0497512; EP 0778275; US 5298520; US 5451588; US 5602162; US 5602163 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 16860 | 4-(1H-1,2,4-triazol-1-ylmethyl)aniline; 4-(1H-1,2,4-triazol-1-ylmethyl)phenylamine | C9H10N4 | 详情 | 详情 | |
| (VI) | 16866 | 1-(Bromomethyl)-4-nitrobenzene; para-Nitrobenzyl bromide | 100-11-8 | C7H6BrNO2 | 详情 | 详情 |
| (VII) | 13104 | 1,2,4-Triazole, sodium derivative | 41253-21-8 | C2H2N3Na | 详情 | 详情 |
| (VIII) | 16868 | 1-(4-nitrobenzyl)-1H-1,2,4-triazole | C9H8N4O2 | 详情 | 详情 | |
| (IX) | 16869 | 1-(4-hydrazinobenzyl)-1H-1,2,4-triazole | C9H11N5 | 详情 | 详情 | |
| (X) | 16870 | 4-Chlorobutyraldehyde dimethylacetal; 4-Chloro-1-methoxybutyl methyl ether; 4-Chloro-1,1-dimethoxybutane | C6H13ClO2 | 详情 | 详情 | |
| (XI) | 16871 | 2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine; 2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]-1-ethanamine | C13H15N5 | 详情 | 详情 |
合成路线3
3) The condensation of 4-nitrobenzyl bromide (VI) with 4-amino-1,2,4-triazole (XII) in refluxing isopropanol gives 4-amino-1-(3-nitrobenzyl)-1,2,4-triazolium bromide (XIII), which is deaminated with NaNO2/HCl to afford 1-(4-nitrobenzyl)-1,2,4-triazole (VIII). The reduction of (VIII) yields amine (I), which by diazotation and reduction with Na2SO3 yields the corresponding hydrazine (IX). Finally, (IX) is cyclized with 4-(dimethylamino)butanal dimethylacetal (XIV) in acidic water.

| 【1】 Castañer, J.; Mealy, N.; Rabassseda, X.; MK-0462. Drugs Fut 1995, 20, 7, 676. |
| 【2】 Baker, R.; Pitt, K.G.; Matassa, V.G.; Storey, D.E.; Olive, C.; Street, L.J. (Merck Sharp & Dohme Ltd.); The sulphate salt of a substd. triazole, pharmaceutical compsns. thereof, and their use in therapy. EP 0573221; US 5527817; WO 9325547 . |
| 中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
|---|---|---|---|---|---|---|
| (I) | 16680 | methyl (2S)-2-(acetylsulfanyl)propanoate | C6H10O3S | 详情 | 详情 | |
| (VI) | 16866 | 1-(Bromomethyl)-4-nitrobenzene; para-Nitrobenzyl bromide | 100-11-8 | C7H6BrNO2 | 详情 | 详情 |
| (VIII) | 16868 | 1-(4-nitrobenzyl)-1H-1,2,4-triazole | C9H8N4O2 | 详情 | 详情 | |
| (XI) | 16869 | 1-(4-hydrazinobenzyl)-1H-1,2,4-triazole | C9H11N5 | 详情 | 详情 | |
| (XII) | 16106 | 4H-1,2,4-triazol-4-amine; 4-Amino-4H-1,2,4-triazole; 4H-1,2,4-triazol-4-ylamine; 4-Amino-1,2,4-triazole | 584-13-4 | C2H4N4 | 详情 | 详情 |
| (XIII) | 16873 | 4-amino-1-(4-nitrobenzyl)-1H-1,2,4-triazol-4-ium bromide | 6085-99-0 | C9H10BrN5O2 | 详情 | 详情 |
| (XIV) | 16874 | N-(4,4-dimethoxybutyl)-N,N-diethylamine; N,N-diethyl-4,4-dimethoxy-1-butanamine | C10H23NO2 | 详情 | 详情 |